DCF ScreenerData as of Oct 10, 2026, 1:06 AM UTC
← Screener

TMO Thermo Fisher Scientific Inc.

Healthcare

Price
$656.58
Intrinsic value
$61.31
Buy price
$49.05
Discount
-971.0%
Overvalued

Live signals (1)

Daily bars as of Oct 8, 2026
  • UCUptrend ContinuationBullish ↑

    A strong bullish bar closing back into a rising 20/50-SMA stack - the uptrend resuming after a pullback to the moving averages.

    Fired Oct 8, 2026on the latest daily bar35.8% win rate · 1x profit factor

A pattern is reported for 5 bars after it fires (the sweet-spot fill window), so an older bar count means the entry has had longer to play out - not that the signal is stronger. Win rate and profit factor are the pattern's backtested averages across the S&P 500, not a forecast for this ticker.

DCF walkthrough

Near-term growth (g1)0.00%
Terminal growth (g2)3.50%
Years of g1 growth4
Discount rate9.00%
Margin of safety20.00%
Operating CF
$9,013,000,000.00
Total debt
$42,548,998,144.00
Cash & STI
$4,064,000,000.00
Shares out.
371,000,000
Overvalued
Intrinsic value$61.33
Buy price (with MOS)$49.07
Current price$656.58
Discount to intrinsic value-970.5%

7-step quality scorecard

ROE quality
LOW
Average ROE
13.5%
Current ROE
12.6%
Minimum ROE
12.6%
Debt quality
MODERATE
Debt / Equity
0.80x
Moat proxy
MODERATE_PROXY
Cash-flow reliability
OK
Operating CF / Net income
1.29x

Technical chart

Confluence: NONE (0/3)

Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim (see Live signals above for when it fired).

Assumptions & data quality

Data source
yfinance
Growth (g1) source
min(cfCAGR,revenueCAGR)
Valuation model
DCF_OCF
Debt as % of DCF PV
69.4%
Public economic interest
99.8%

These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.